<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-09-21T19:38:20Z</responseDate><request verb="GetRecord" identifier="oai:www.repository.cam.ac.uk:1810/349188" metadataPrefix="uketd_dc">https://api.repository.cam.ac.uk/server/oai/request</request><GetRecord><record><header><identifier>oai:www.repository.cam.ac.uk:1810/349188</identifier><datestamp>2023-12-22T13:31:20Z</datestamp><setSpec>com_1810_217840</setSpec><setSpec>com_1810_34581</setSpec><setSpec>col_1810_218541</setSpec></header><metadata><uketd_dc:uketddc xmlns:uketd_dc="http://naca.central.cranfield.ac.uk/ethos-oai/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:uketdterms="http://naca.central.cranfield.ac.uk/ethos-oai/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://naca.central.cranfield.ac.uk/ethos-oai/2.0/ http://naca.central.cranfield.ac.uk/ethos-oai/2.0/uketd_dc.xsd">
   <dc:title>Quantitative Analyses of Normal and Precancerous Somatic Evolution in Human Tissues</dc:title>
   <dc:identifier xsi:type="dcterms:DOI">https://doi.org/10.17863/CAM.96459</dc:identifier>
   <dc:creator>Poon, Yeuk Pin Gladys</dc:creator>
   <uketdterms:advisor>Blundell, Jamie</uketdterms:advisor>
   <dcterms:abstract>Cancer arises from a single cell of origin whose lineage accumulates somatic mutations
in a step-wise manner over time. The evolutionary process towards cancer development
is dynamic and the earliest mutation may arise decades before the onset for some cancers.
This calls for a quantitative approach for probing early cancer evolution using measurable
quantities in normal and precancerous tissues.
Genetic alterations under positive selection in ostensibly healthy tissues have implica tions for cancer risk. However, total levels of positive selection across the genome remain
unknown. How much positive selection elsewhere in the genome is missed by gene-focused
sequencing panels? Synonymous passenger mutations that hitchhike to high variant allele
frequency are influenced by any driver mutation, regardless of type or location in the genome,
and can therefore be used to estimate total levels of positive selection in healthy tissues. By
comparing observed numbers of synonymous passengers to the numbers expected due to
driver mutations in canonical cancer genes, we showed in chapter 2 and 3 that it is possible
to quantify missing selection left to be explained by unobserved drivers elsewhere in the
genome. We analysed the variant allele frequency spectrum of synonymous mutations from
physiologically healthy blood and oesophagus to quantify levels of missing positive selection.
In blood we found that only ∼ 30% of synonymous passengers can be explained by SNVs
in canonical driver genes, suggesting high levels of positive selection for other mutations
elsewhere in the genome. In contrast, approximately half of all synonymous passengers in
the oesophagus can be explained by just the two driver genes NOTCH1 and TP53, suggesting
little positive selection elsewhere. In tissues with high levels of ‘missing’ selection, we
showed that our framework can be used to guide targeted driver mutation discovery.
In chapter 5 we used single-cell DNA sequencing of >2000 preleukemic haematopoietic
stem cells across 8 DNMT3Amut/NPM1c acute myeloid leukemia (AML) patients to reveal
the patterns of driver mutation co-occurrence in ostensibly healthy stem cells. We constructed
phylogenetic trees using preleukemic HSCs for all eight patients and assigned cells to tree
nodes based on both single-cell and bulk sequencing information. We found that in all cases
the development of AML required a single cell to acquire 3-4 key driver events. Mutation
co-occurrence patterns and mutation acquisition orders were consistent with findings from
other studies. Using a model developed in chapter 4, we gained power in using evolutionary
histories revealed by clonal trees to separate out parametrical influence of the two major
parameters µ and s in preleukemic evolution. We showed that the k-hit staircase model
makes many tractable predictions regarding variation across individuals and large variations
are not unexpected from the inherent stochasticity of the process.
We gained important insights into precancerous evolutionary dynamics by performing
quantitative analyses on genetics data obtained from both normal and preleukemic tissues.
What we presented here shows that quantitative approaches combined with clear model
hypotheses carry explanatory powers to explain observed patterns in genetics data with
reference to the mechanisms and processes of early cancers</dcterms:abstract>
   <uketdterms:institution>University of Cambridge</uketdterms:institution>
   <dcterms:issued>2022-09-30</dcterms:issued>
   <dc:type>Thesis</dc:type>
   <uketdterms:qualificationlevel>Doctoral</uketdterms:qualificationlevel>
   <uketdterms:qualificationname>Doctor of Philosophy (PhD)</uketdterms:qualificationname>
   <dc:language>eng</dc:language>
   <dcterms:isReferencedBy xsi:type="dcterms:URI">https://www.repository.cam.ac.uk/handle/1810/349188</dcterms:isReferencedBy>
   <dcterms:license>https://apollo8-f-pro.lib.cam.ac.uk/bitstreams/48b34129-1e0e-4b17-9ac4-e23883854c42/download</dcterms:license>
   <uketdterms:checksum xsi:type="uketdterms:MD5">87eda9de84448d1f82354d60eee3eb5f</uketdterms:checksum>
   <dc:identifier xsi:type="dcterms:URI">https://apollo8-f-pro.lib.cam.ac.uk/bitstreams/9cf5ec09-07c4-4022-bdaf-e35ea0c1c69d/download</dc:identifier>
   <uketdterms:checksum xsi:type="uketdterms:MD5">ab9d2a3115fecf3a8552e3140d7181b5</uketdterms:checksum>
   <dc:rights>https://www.rioxx.net/licenses/all-rights-reserved/</dc:rights>
   <dc:subject>acute myeloid leukemia</dc:subject>
   <dc:subject>clonal haematopoiesis</dc:subject>
   <dc:subject>early cancer</dc:subject>
   <dc:subject>genetic hitchhiking</dc:subject>
   <dc:subject>preleukemic evolution</dc:subject>
   <dc:subject>quantitative</dc:subject>
   <dc:subject>somatic evolution</dc:subject>
</uketd_dc:uketddc>
</metadata></record></GetRecord></OAI-PMH>